Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up  |  Already a member? Sign In  |  Visit IQPC.com  
Pharma IQ



About this Podcast...


Congenital heart disease is the most common birth defect in newborn babies, as 8 out of 1,000 babies born each year have the disease. Some forms will cause few problems, but criticial cases can bring about cardiogenic shock or even death if a child is left undiagnosed. The procedure to test a baby for congenital heart disease is non-invasive and simple and most hospitals currently have the means to carry it out, but many are not. Two hospitals in Abu Dhabi are currently testing babies that are over 24 hours old for the heart defect -  Dr. Jennifer Moore, Section Head, Family and School Health, Health Authority Abu Dhabi UAE and Dr. Shereena Al Mazrouie, Senior Officer, Family and School Health, Health Authority Abu Dhabi, UAE explain to Pharma IQ.

*Click here for more information on the 2nd Annual GCC Paediatric Summit

Have Your Say
Rate this feature and give us your feedback in the comments section below
Rate this Podcast: (5.0 Stars | 1 Vote)



Advertisement

Events of Interest
Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.